[1] Fukui H, Saito H, Ueno Y, et al. Evidence-based clinical practice guidelines for liver cirrhosis 2015. J Gastroenterol, 2016,51:629-650.
[2] Seo YS. Prevention and management of gastroesophageal varices. Clin Mol Hepatol, 2018,24:20-42.
[3] de Franchis R. Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol, 2015,63:743-752.
[4] EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. J Hepatol, 2018,69:406-460.
[5] Reiberger T, Ulbrich G, Ferlitsch A, et al. Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol. Gut, 2013,62:1634-1641.
[6] 史慧敏,李瑞,陈红,等.《2018年欧洲肝病学会失代偿期肝硬化患者的管理临床实践指南》摘译.临床肝胆病杂志,2018:1632-1638.
[7] 戚虎昶,凌静,卢芳芳.特利加压素临床研究进展.解放军药学学报,2012,28:169-172.
[8] Seo YS, Park SY, Kim MY, et al. Lack of difference among terlipressin, somatostatin, and octreotide in the control of acute gastroesophageal variceal hemorrhage. Hepatology, 2014,60:954-963.
[9] Tripathi D, Stanley AJ, Hayes PC, et al. U.K. guidelines on the management of variceal haemorrhage in cirrhotic patients. Gut, 2015,64:1680-1704.
[10] Kang SH, Yim HJ, Kim SY, et al. Proton pump inhibitor therapy is associated with reduction of early bleeding risk after prophylactic endoscopic variceal band ligation: a retrospective cohort study. Medicine, 2016,95:e2903.
[11] 陈梦诗,林志辉.食管胃底静脉曲张破裂出血的药物治疗.创伤与急诊电子杂志,2016,4:240-243.
[12] Abraldes JG, Villanueva C, Aracil C, et al. Addition of Simvastatin to Standard Therapy for the Prevention of Variceal Rebleeding Does Not Reduce Rebleeding but Increases Survival in Patients With Cirrhosis. Gastroenterology, 2016,150:1160-1170.e3.
[13] Wan S, Huang C, Zhu X. Systematic review with a meta-analysis: clinical effects of statins on the reduction of portal hypertension and variceal haemorrhage in cirrhotic patients. BMJ open, 2019,9:e030038.
[14] 徐小元,丁惠国,贾继东,等.肝硬化门静脉高压食管胃静脉曲张出血的防治指南.临床肝胆病杂志,2016:203-219.
[15] Onofrio FQ, Pereira-Lima JC, Valenca FM, et al. Efficacy of endoscopic treatments for acute esophageal variceal bleeding in cirrhotic patients: systematic review and meta-analysis. Endosc Int Open, 2019,7:E1503-e14.
[16] Sarin SK, Wadhawan M, Agarwal SR, et al. Endoscopic variceal ligation plus propranolol versus endoscopic variceal ligation alone in primary prophylaxis of variceal bleeding. Am J Gastroenterol, 2005,100:797-804.
[17] Al-Khazraji A, Curry MP. The current knowledge about the therapeutic use of endoscopic sclerotherapy and endoscopic tissue adhesives in variceal bleeding. Expert Rev Gastroenterol Hepatol, 2019,13:893-897.
[18] 江长文,汪安江,张金莲,等.肝硬化食管静脉曲张破裂出血的内镜治疗.临床肝胆病杂志,2019:1365-1368.
[19] 陈思如,何夕昆,李永仙,等.内镜下组织胶治疗胃静脉曲张进展的评述.现代消化及介入诊疗,2014,19:33-36.
[20] Ye X, Huai J, Chen Y. Cyanoacrylate injection compared with band ligation for acute gastric variceal hemorrhage: a meta-analysis of randomized controlled trials and observational studies. Gastroenterol Res and Pract, 2014,2014:806586.
[21] 李爽,陆伟, 崔树波,等.超声内镜在食管胃底静脉曲张治疗及预后评估中的作用.临床肝胆病杂志,2016:2268-2272.
[22] Mohan BP, Chandan S, Khan SR, et al. Efficacy and safety of endoscopic ultrasound-guided therapy versus direct endoscopic glue injection therapy for gastric varices: systematic review and meta-analysis. Endoscopy, 2020,52:259-267.
[23] Marot A, Trepo E, Doerig C, et al. Self-expanding metal stent should be considered in patients with cirrhosis and uncontrolled variceal bleeding. Hepatology, 2016,64:2273.
[24] Wright G, Lewis H, Hogan B, et al. A self-expanding metal stent for complicated variceal hemorrhage: experience at a single center. Gastrointest Endosc, 2010,71:71-78.
[25] Marot A, Trepo E, Doerig C, et al. Systematic review with meta-analysis: self-expanding metal stents in patients with cirrhosis and severe or refractory oesophageal variceal bleeding. Alimen Pharmacol Ther, 2015,42:1250-1260.
[26] Jalan R, Forrest EH, Stanley AJ, et al. A randomized trial comparing transjugular intrahepatic portosystemic stent-shunt with variceal band ligation in the prevention of rebleeding from esophageal varices. Hepatology, 1997,26:1115-1122.
[27] Azoulay D, Castaing D, Majno P, et al. Salvage transjugular intrahepatic portosystemic shunt for uncontrolled variceal bleeding in patients with decompensated cirrhosis. J Hepatol, 2001,35:590-597.
[28] Hernandez-Gea V, Procopet B, Giraldez A, et al. Preemptive-TIPS Improves Outcome in High-Risk Variceal Bleeding: An Observational Study. Hepatology, 2019,69:282-293.
[29] Shreve L, Lee EW. Role of Interventional Radiology in Complications of Portal Hypertension. J Clin Gastroenterol, 2019,53:342-934.
[30] Park JK, Saab S, Kee ST, et al. Balloon-occluded retrograde transvenous obliteration (BRTO) for treatment of gastric varices: review and meta-analysis. Dig Dis Sci, 2015,60:1543-1553.
[31] Gwon DI, Ko GY, Yoon HK, et al. Gastric varices and hepatic encephalopathy: treatment with vascular plug and gelatin sponge-assisted retrograde transvenous obliteration--a primary report. Radiology, 2013,268:281-287.
[32] Yamamoto A, Jogo A, Kageyama K, et al. Utility of Coil-Assisted Retrograde Transvenous Obliteration II (CARTO-II) for the treatment of gastric varices. Cardiovasc Intervent Radiol, 2020,43(4):565-571.
[33] 杨连粤,白雪莉. 肝硬化门静脉高压症食管、胃底静脉曲张破裂出血诊治专家共识(2019版).中国实用外科杂志,2019:1241-1247. |
